Trupanion Reports First Quarter 2024 Results
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and […]
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Commercial launch of INPEFA®(sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1 Diabetes […]
Model N Announces Date of Second Quarter Fiscal Year 2024 Financial Results
SAN MATEO, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Model N, Inc. (NYSE: MODN), a leader in revenue optimization and […]
QIAGEN verbessert Bioinformatik-Workflows mit neuer Sekundäranalyse-Lösung für Onkologie und Erbkrankheiten
VENLO, Niederlande, und REDWOOD CITY, Kalifornien, May 02, 2024 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) […]
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
Venlo, the Netherlands, and Redwood City, California, May 02, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) […]
TSX News -
Badger Announces Voting Results of 2024 Annual Meeting of Shareholders
CALGARY, Alberta, May 02, 2024 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) is […]
Precision Drilling Corporation Holding Virtual-Only 2024 Annual and Special Meeting of Shareholders on May 16
CALGARY, Alberta, May 02, 2024 (GLOBE NEWSWIRE) — Precision Drilling Corporation (Precision) would like to remind shareholders that it is […]
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 […]
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment in the second quarter of 2024. Ended the […]
Clearfield Reports Second Quarter 2024 Results
Revenue of $36.9 million and net loss per share of $(0.40) – both above the high end of their respective […]
